Persistence of anti-HBs antibodies in healthy Iranian children vaccinated with recombinant hepatitis B vaccine and response to a booster dose

Acta Medica Iranica

Volumn 43, Issue 2, 2005, Pages 79-84

  Jafarzadeh, A ^a   Sajjadi, S M A ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HBs antibodies; Booster vaccination; Children; Hepatitis B vaccine

Indexed keywords

HEBERBIOVAC; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IRAN; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PERSISTENT VIRUS INFECTION; PRIMARY PREVENTION; SEROCONVERSION; VACCINATION;

EID: 26244466759     PISSN: 00446025     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003 Feb; 23(1):39-46.
2. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000 Feb 18; 18 Suppl 1:S20-22.
3. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003 May; 24(5):549-551.
4. Goldstein ST, Fiore AE. Toward the global elimination of hepatitis B virus transmission. J Pediatr. 2001 Sep; 139(3):343-345.
5. Mass R, Delage G. Universal hepatitis B immunization: infants and plus adolescent immunization. Vaccine 1998; 16(suppl 1):S17-S22.
6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002 Jul; 2(7):395-403.
7. Lankarani KB, Taghavi AR, Agah S, Karimi A. Comparison of intradermal and intramuscular administration of hepatitis B vaccine in neonates. Indian J Gastroenterol. 2001 May-Jun; 20(3):94-96.
8. Zannolli R, Morgese G. Hepatitis B vaccine: current issues. Ann Pharmacother. 1997 Sep; 31(9):1059-1067.
9. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine. 1996 Aug; 14(11):1019-1027.
10. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000 Nov 22; 19(7-8):877-885.
11. Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine -induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995; 13:443-447.
12. Jafarzadeh A, Shokti F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol. 2003 Mar; 131(3):451-456.
13. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine. 2001 Aug 14; 19(31):4544-4548.
14. Jafarzadeh A, Kardar GA, Khoshnoodi J, Shokri F. Downregulation of IL-12 production in healthy non-responder neonates to recombinant hepatitis B vaccine. Iran Biomed J. 2004; 8:41-45.
15. Jafarzadeh A, Shokrgozar MA, Khoshnoodi J, Shokri F. Unresponsiveness to recombinant hepatitis B vaccine in healthy Iranian neonates: association with HLA antigens. Im J Med Sci. 2002; 27:51-55.
16. Kurugol Z, Erensoy S, Aksit S, Egemen A, Bilgic A. Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study. Vaccine. 2001 Jul 16; 19(28-29):3936-3939.
17. Seto D, West DJ, Ioli VA. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J. 2002 Aug; 21(8):793-795.
18. Belloni C, Pistorio A, Tinelli C, Komakec J, Chirico G, Rovelli D, Gulminetti R, Comolli G, Orsolini P, Rondini G. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine. 2000 Jan 31; 18(14):1307-1311.
19. Watson B, West DJ, Chilkatowsky A, Piercy S, Ioli VA. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine. 2001 Apr 30; 19(23-24):3164-3168.
20. Wang RX, Boland GJ, van Hattum J, de Gast GC. ng-term persistence of T cell memory to HBsAg after hepatitis B vaccination. World J Gastroenterol. 2004 Jan 15; 10(2):260-3.
21. Williams JL, Christensen CJ, McMahon BJ, Bulkow LR. Evaluation of response to a booster dose of hepatitis B vaccine in previously immunized health care workers. Vaccine 2001; 19:4081-4085.
22. Banatvala JE, Van Damme P. Hepatitis B vaccine - do we need boosters? J Viral Hepat. 2003 Jan; 10(1):1-6.
23. Trivello R, Chiaramonte M, Ngatchu T, Baldo V, Majori S, Moschen ME, Simoncello I, Renzulli G, Naccarato R. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine. 1995 Feb; 13(2):139-141.
24. Ayerbe MC, Perez-Rivilla A; ICOVAHB group. Assessment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol. 2001; 17(2):150-156.
25. Bucher B, Francioli P, Geudelin B, Fritzell B, Lavanchy D, Frei PC. Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster. Eur J Clin Microbiol Infect Dis. 1994 Mar; 13(3):212-7.
26. Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol. 1998 Dec; 4(6):493-496.
27. Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J. 2003 Feb; 22(2):157-63.
28. Wistrom J, Ahlm C, Lundberg S, Settergren B, Taravik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine. 1999 Apr 23; 17(17):2162-5.
29. Milne A, Waldon J. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years. J Infect Dis. 1992 Oct; 166(4):942.
30. Milne A, Krugman S, Waldon JA, Hadler SC, Lucas CR, Moyes CD, Pearce NE. Hepatitis B vaccination in children: five year booster study. N Z Med J. 1992 Aug 26; 105(940):336-338.
31. Milne A, Hopkirk N, Moyes CD. Hepatitis B vaccination in children: persistence of immunity at 9 years. J Med Virol. 1994 Oct; 44(2):113-114.
32. Resti M, Di Francesco G, Azzari C, Rossi ME, Vierucci A. Anti-HBs and immunological memory to HBV vaccine: implication for booster timing. Vaccine. 1993; 11(10):1079.
33. Gonzalez ML, Gonzalez JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine. 1993; 11(10):1033-1036.